funder-graph

FundersTN

Grants paid by Herb Kosten Pancreatic Cancer Charitable Fund

EIN 86-1129030 · Memphis, TN · Form 990, Schedule I · NTEE H12

Herb Kosten Pancreatic Cancer Charitable Fund of Memphis, TN (EIN 86-1129030) reported 16 grants paid totaling $765,000 to 6 recipients in tax years 2018–2025, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.

Grants paid

$765,000

16 grants

Recipients

6

distinct organizations

Tax years

2018–2025

6 filings in the corpus

By tax year

Grants by tax year, as the same figures
Tax yearGrants paidAmount paidApproved for future
20181$150,000
20203$185,000
20223$180,000
20232$80,000
20244$170,000
20253$0

Top recipients

The 6 recipients receiving the most from Herb Kosten Pancreatic Cancer Charitable Fund, by grants paid, out of 6 distinct recipients.

Recipients ranked by total grants paid
RecipientMatchLocationGrantsTotal paidLatest year
The University of Texas Southwestern Medical Center 47-4682690DDallas, TX5$270,0002025
School of Medicine University of Texas Rio Grande ValleyUEdinburg, TX4$190,0002025
The University of Tennessee Health SciencesUMemphis, TN1$150,0002018
Baptist Memorial Hospital 62-0123940BMemphis, TN4$105,0002024
Nyu Grossman School of MedicineUNew York, NY1$50,0002024
Nyu Langone Health 47-2613531CNew York, NY1$02025

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Every grant

All 16 grant rows this organization reported, most recent first.

Grants reported by Herb Kosten Pancreatic Cancer Charitable Fund
Tax yearRecipientMatchAmountTypePurposeSource filing
2025The University of Texas Southwestern Medical Center Dallas, TXD$0 + $65,000 non-cashpaidFUNDS TO AID IN RESEARCH EFFORTS.202601359349306270
2025School of Medicine University of Texas Rio Grande Valley Edinburg, TXU$0 + $65,000 non-cashpaidRESEARCH FOR PROJECT TITLED NOVEL THERAPEUTIC APPROACH FOR PANCREATIC CANCER202601359349306270
2025Nyu Langone Health New York, NYC$0 + $65,000 non-cashpaidFUNDS TO AID IN RESEARCH EFFORTS.202601359349306270
2024The University of Texas Southwestern Medical Center Dallas, TXD$60,000paidFUNDS TO AID IN RESEARCH EFFORTS.202532879349301623
2024Nyu Grossman School of Medicine New York, NYU$50,000paidFUNDS TO AID IN RESEARCH EFFORTS.202532879349301623
2024School of Medicine University of Texas Rio Grande Valley Edinburg, TXU$50,000paidRESEARCH FOR PROJECT TITLED NOVEL THERAPEUTIC APPROACH FOR PANCREATIC CANCER202532879349301623
2024Baptist Memorial Hospital Memphis, TNB$10,000paidRESEARCH FUNDS FOR PROJECT TITLED: OUTCOMES FOLLOWING NEOADJUVANT CHEMORADIATION AND ASSESSMENT OF GENETIC AND SOMATIC ALTERATIONS IN ANCILLARY AND DUODENAL ADENOCARCINOMA202532879349301623
2023The University of Texas Southwestern Medical Center Dallas, TXD$60,000paidFUNDS TO AID IN RESEARCH EFFORTS.202443059349302504
2023Baptist Memorial Hospital Memphis, TNB$20,000paidRESEARCH FUNDS FOR PROJECT TITLED: OUTCOMES FOLLOWING NEOADJUVANT CHEMORADIATION AND ASSESSMENT OF GENETIC AND SOMATIC ALTERATIONS IN ANCILLARY AND DUODENAL ADENOCARCINOMA202443059349302504
2022School of Medicine University of Texas Rio Grande Valley Edinburg, TXU$80,000paidRESEARCH FOR PROJECT TITLED NOVEL THERAPEUTIC APPROACH FOR PANCREATIC CANCER202341449349301209
2022The University of Texas Southwestern Medical Center Dallas, TXD$75,000paidFUNDS TO AID IN RESEARCH EFFORTS.202341449349301209
2022Baptist Memorial Hospital Memphis, TNB$25,000paidRESEARCH FUNDS FOR PROJECT TITLED: OUTCOMES FOLLOWING NEOADJUVANT CHEMORADIATION AND ASSESSMENT OF GENETIC AND SOMATIC ALTERATIONS IN ANCILLARY AND DUODENAL ADENOCARCINOMA202341449349301209
2020The University of Texas Southwestern Medical Center Dallas, TXD$75,000paidFUNDS TO HIRE DATA ANALYST202141739349300909
2020School of Medicine University of Texas Rio Grande Valley Edinburg, TXU$60,000paidRESEARCH FOR PROJECT TITLED NOVEL THERAPEUTIC APPROACH FOR PANCREATIC CANCER202141739349300909
2020Baptist Memorial Hospital Memphis, TNB$50,000paidRESEARCH FUNDS FOR PROJECT TITLED: OUTCOMES FOLLOWING NEOADJUVANT CHEMORADIATION AND ASSESSMENT OF GENETIC AND SOMATIC ALTERATIONS IN ANCILLARY AND DUODENAL ADENOCARCINOMA202141739349300909
2018The University of Tennessee Health Sciences Memphis, TNU$150,000paidRESEARCH201911699349301111

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Source filings

Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.

Returns this page is derived from
FormTax yearPeriod endFiledSchemaIRS OBJECT_ID
99020252025-12-31not stated2025v4.1202601359349306270
99020242024-12-31not stated2024v5.2202532879349301623
99020232023-12-31not stated2023v5.1202443059349302504
99020222022-12-31not stated2022v5.0202341449349301209
99020202020-12-31not stated2020v4.1202141739349300909
99020182018-12-31not stated2018v3.1201911699349301111

Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/861129030.json.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.